Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun 16;10(2):109-116.
doi: 10.1055/s-0043-1770056. eCollection 2023 Jun.

Association of Interleukin-1 Receptor Antagonist ( IL-1RA ) Gene Polymorphism with Community-Acquired Pneumonia in North Indian Children: A Case-Control Study

Affiliations

Association of Interleukin-1 Receptor Antagonist ( IL-1RA ) Gene Polymorphism with Community-Acquired Pneumonia in North Indian Children: A Case-Control Study

Neha Verma et al. Glob Med Genet. .

Abstract

Background Community-acquired pneumonia (CAP) is the leading cause of death in children < 5 years of age. The primary objective of the study was to assess the association of IL-1RA gene polymorphism in children aged 2 to 59 months with CAP and the secondary objective was to assess the association of gene polymorphism with mortality among hospitalized CAP cases. Study Design This case-control study was conducted in a tertiary teaching institute in Northern India. Hospitalized children aged 2 to 59 months with World Health Organization-defined CAP were included as cases after parental consent. Age-matched healthy controls were recruited from the immunization clinic of the hospital. Genotyping was done using polymerase chain reaction to analyze the variable number of tandem repeats of IL-1RA gene polymorphism. Result From October 2019 to October 2021, 330 cases (123, 37.27% female), and 330 controls (151, 45.75% female) were recruited. Genotype A2/A2 of the IL-1RA gene was found to be associated with the increased risk for CAP children with adjusted odds ratio (AOR) of 12.24 (95% confidence interval [CI] 5.21-28.7, p < 0.001). A2 and A4 alleles were also found to be at risk for CAP. A1/A2 genotype was found to be protective for CAP with an AOR of 0.29 (95% CI 0.19-19.0.45). The genotype A2/A2 and A2 allele of IL-1RA gene was associated with child mortality with CAP cases. Conclusion In IL1RA gene, A2/A2 genotype and A2 allele were associated with increased risk of CAP and A1/A2 were found to be protective for CAP. The genotype A2/A2 and A2 was associated with CAP mortality.

Keywords: adjusted odds ratio; community-acquired pneumonia; interleukin-1 receptor antagonist; odds ratio; polymerase chain reaction; variable number of tandem repeats.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest The author(s) declare that there is no conflict of interest.

Figures

Fig. 1
Fig. 1
Flowchart of the study. CAP, community-acquired pneumonia; CHD, congenital heart disease; TBM, tubercular meningitis; WHO, World Health Organization.

Similar articles

Cited by

References

    1. World Health Organization (WHO a) 2021. Accessed July 2, 2022 at:https://www.who.int/news-room/fact-sheets/detail/pneumonia
    1. Patwari P P, O'Cain P, Goodman D M. Interleukin-1 receptor antagonist intron 2 variable number of tandem repeats polymorphism and respiratory failure in children with community-acquired pneumonia. Pediatr Crit Care Med. 2008;9(06):553–559. - PMC - PubMed
    1. Awasthi S, Yadav K K, Pandey M, Mahdi A A, Awasthi N. Interleukin 1 receptor antagonist (IL1RA) gene polymorphism and levels associated with adverse outcome in severe community-acquired pneumonia in children: a hospital-based study in India. Pediatr Pulmonol. 2018;53(09):1276–1283. - PubMed
    1. Santtila S, Savinainen K, Hurme M. Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1beta production in vitro. Scand J Immunol. 1998;47(03):195–198. - PubMed
    1. Wardlaw T, Johanssan E W, Hodge M.Pneumonia: the forgotten killer of childrenUNICEF and WHO. 2006. Accessed May 26, 2016 at:http://apps.who.int/iris/bitstream/10665/43640/1/9280640489_eng.pdf